Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | VP, Finance & CAO | May 05, 2023 | May 09, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date May 05, 2023 · Filed May 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,966 |
Reported balance
After 2023-05-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-05 · Tax withholding · Disposed 16 · Balance 9,966 F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 58 RSUs which will vest on 5/5/2024; 974 RSUs which will vest in installments of 479 on 11/2/2023 and 495 on 11/2/2024; 201 RSUs which will vest in installments of 99 on 4/30/2024 and 102 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026; and 423 RSUs which will vest in installments of 139 on 5/2/2025, 140 on 5/2/2026 and 144 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2: These shares include 123 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 58 RSUs which will vest on 5/5/2024; 974 RSUs which will vest in installments of 479 on 11/2/2023 and 495 on 11/2/2024; 201 RSUs which will vest in installments of 99 on 4/30/2024 and 102 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026; and 423 RSUs which will vest in installments of 139 on 5/2/2025, 140 on 5/2/2026 and 144 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2: These shares include 123 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2023 Filed May 9, 2023 23:21 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 16 | $231.89 | $3,710.24 |
DisclosureSEC source: 0001127602-23-015049 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,966 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 58 RSUs which will vest on 5/5/2024; 974 RSUs which will vest in installments of 479 on 11/2/2023 and 495 on 11/2/2024; 201 RSUs which will vest in installments of 99 on 4/30/2024 and 102 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026; and 423 RSUs which will vest in installments of 139 on 5/2/2025, 140 on 5/2/2026 and 144 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 123 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 02, 2023 Filed May 5, 2023 00:30 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 3,583 | $0.00 Strike: $235.97 | $0.00 |
DisclosureSEC source: 0001127602-23-014610 · form4.xml · derivative · entry 3 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,583 Underlying: Common Stock · 3,583 shares Expires 2033-05-02 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively. Read SEC document |
| May 02, 2023 Filed May 5, 2023 00:30 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 20 | $235.97 | $4,719.40 |
DisclosureSEC source: 0001127602-23-014610 · form4.xml · nonDerivative · entry 2 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,982 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 114 RSUs which will vest in installments of 56 on 5/5/2023 and 58 on 5/5/2024; 974 RSUs which will vest in installments of 479 on 11/2/2023 and 495 on 11/2/2024; 201 RSUs which will vest in installments of 99 on 4/30/2024 and 102 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026; and 423 RSUs which will vest in installments of 139 on 5/2/2025, 140 on 5/2/2026 and 144 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 127 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 02, 2023 Filed May 5, 2023 00:30 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 423 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014610 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,002 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2025, 5/2/2026 and 5/2/2027, respectively. Read SEC document |
| April 30, 2023 Filed May 3, 2023 00:24 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 27 | $239.74 | $6,472.98 |
DisclosureSEC source: 0001127602-23-014155 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,579 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 67 RSUs which will vest on 5/3/2023; 114 RSUs which will vest in installments of 56 on 5/5/2023 and 58 on 5/5/2024; 974 RSUs which will vest in one installment of 479 on 11/2/2023 and one installment of 495 on 11/2/2024; 201 RSUs which will vest in one installment of 99 on 4/30/2024 and one installment of 102 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; and 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 136 DEs granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 17, 2023 Filed Mar 20, 2023 23:12 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 96 | $234.57 | $22,518.72 |
DisclosureSEC source: 0001127602-23-010919 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,606 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 67 RSUs which will vest on 5/3/2023; 114 RSUs which will vest in installments of 56 on 5/5/2023 and 58 on 5/5/2024; 974 RSUs which will vest in one installment of 479 on 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which will vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; and 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 142 DEs granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 06, 2023 Filed Mar 9, 2023 00:06 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 387 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009497 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,679 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 67 RSUs which will vest on 5/3/2023; 114 RSUs which will vest in installments of 56 on 5/5/2023 and 58 on 5/5/2024; 974 RSUs which will vest in one installment of 479 on 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which will vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; and 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 122 DEs granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 05, 2022 Filed Nov 8, 2022 23:43 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 45 | $269.04 | $12,106.80 |
DisclosureSEC source: 0001127602-22-025156 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,278 F1 · shares: 45 shares issuable upon the vesting of Restricted Stock Units (RSUs) and related Dividend Equivalents (DEs) on 11/5/2022 were withheld by the Company to cover related tax withholding obligations. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 67 RSUs which vest on 5/3/2023; 114 RSUs which will vest in installments of 56 on 5/5/2023 and 58 on 5/5/2024; 974 RSUs which vest in installment of 479 on 11/2/2023 and 495 on 11/2/2024; 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; and 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026.. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 108 DEs granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 02, 2022 Filed Nov 4, 2022 01:36 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 125 | $272.06 | $34,007.50 |
DisclosureSEC source: 0001127602-22-024929 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,323 F1 · shares: 125 shares issuable upon the vesting of Restricted Stock Units (RSUs) and related Dividend Equivalents (DEs) on 11/2/2022 were withheld by the Company to cover related tax withholding obligations. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 67 RSUs which will vest on 5/3/2023; 114 RSUs which will vest in installments of 56 on 5/5/2023 and 58 on 5/5/2024; 974 RSUs which will vest in one installment of 479 on 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which will vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; 350 RSUs which will vest in two installments of 175 on 11/5/2022 and 11/5/2023; and 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 113 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 05, 2022 Filed May 9, 2022 23:09 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 15 | $236.10 | $3,541.50 |
DisclosureSEC source: 0001127602-22-013874 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,404 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 67 RSUs which vest in an installment of 67 on 5/3/2023; 114 RSUs which vest in installments of 56 on 5/5/2023 and 58 on 5/5/2024; 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; 350 RSUs which will vest in two installments of 175 on 11/5/2022 and 11/5/2023; and 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026.. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 99 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 03, 2022 Filed May 5, 2022 00:02 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 18 | $230.92 | $4,156.56 |
DisclosureSEC source: 0001127602-22-013350 · form4.xml · nonDerivative · entry 2 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,419 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 67 RSUs which vest in an installment of 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; 350 RSUs which will vest in two installments of 175 on 11/5/2022 and 11/5/2023; and 433 RSUs which will vest in installments of 142 on 5/2/2024, 143 on 5/2/2025, and 148 on 5/5/2026.. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 102 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 02, 2022 Filed May 5, 2022 00:02 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 3,535 | $0.00 Strike: $230.92 | $0.00 |
DisclosureSEC source: 0001127602-22-013350 · form4.xml · derivative · entry 3 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,535 Underlying: Common Stock · 3,535 shares Expires 2032-05-02 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively. Read SEC document |
| May 02, 2022 Filed May 5, 2022 00:02 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013350 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,437 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/2/2024, 5/2/2025 and 5/2/2026, respectively. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:44 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 17 | $249.87 | $4,247.79 |
DisclosureSEC source: 0001127602-22-012764 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,004 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 132 RSUs which vest in installments of 65 on 5/3/2022 and 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; and 350 RSUs which will vest in two installments of 175 on 11/5/2022 and 11/5/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 107 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 21:44 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 108 | $235.86 | $25,472.88 |
DisclosureSEC source: 0001127602-22-010196 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,021 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 58 RSUs which will vest on 4/27/2022; 132 RSUs which vest in installments of 65 on 5/3/2022 and 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; and 350 RSUs which will vest in two installments of 175 on 11/5/2022 and 11/5/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 115 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 00:31 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008136 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,104 F1 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 58 RSUs which will vest on 4/27/2022; 132 RSUs which vest in installments of 65 on 5/3/2022 and 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; and 350 RSUs which will vest in two installments of 175 on 11/5/2022 and 11/5/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 94 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 05, 2021 Filed Nov 10, 2021 01:14 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-028758 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,647 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in two annual installments of 50% on 11/5/2022 and 11/5/2023, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 58 RSUs which will vest on 4/27/2022; 132 RSUs which vest in installments of 65 on 5/3/2022 and 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024; 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025; and 350 RSUs which will vest in two installments of 175 on 11/5/2022 and 11/5/2023. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 73 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 03, 2021 Filed May 4, 2021 23:35 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 17 | $239.64 | $4,073.88 |
DisclosureSEC source: 0001127602-21-015362 · form4.xml · nonDerivative · entry 3 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,266 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 58 RSUs which will vest on 4/27/2022; 132 RSUs which vest in installments of 65 on 5/3/2022 and 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024; and 300 RSUs which vest in two installments of 99 on 4/30/2023 and 4/30/2024 and one installment of 102 on 4/30/2025. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 42 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| May 01, 2021 Filed May 4, 2021 23:35 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 18 | $239.64 | $4,313.52 |
DisclosureSEC source: 0001127602-21-015362 · form4.xml · nonDerivative · entry 2 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,283 Read SEC document |
| April 30, 2021 Filed May 4, 2021 23:35 UTC | AMGEN INC AMGN · Entity 2832 | GrantNqso (Right to Buy) · Derivative | 2,608 | $0.00 Strike: $239.64 | $0.00 |
DisclosureSEC source: 0001127602-21-015362 · form4.xml · derivative · entry 4 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,608 Underlying: Common Stock · 2,608 shares Expires 2031-04-30 F4 · derivative.exercise_date: These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively. Read SEC document |
| April 30, 2021 Filed May 4, 2021 23:35 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-015362 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,301 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/30/2023, 4/30/2024 and 4/30/2025, respectively. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 00:11 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 16 | $255.52 | $4,088.32 |
DisclosureSEC source: 0001127602-21-014603 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,001 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 63 RSUs which will vest on 5/1/2021; 58 RSUs which will vest on 4/27/2022; 197 RSUs which vest in two installments of 65 on 5/3/2021 and 5/3/2022 and one installment of 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; and 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment of 495 on 11/2/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 52 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 19, 2021 Filed Mar 22, 2021 22:31 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 115 | $244.42 | $28,108.30 |
DisclosureSEC source: 0001127602-21-011713 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,017 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 63 RSUs which fully vest on 5/1/2021; 114 RSUs which vest in two installments of 56 on 4/27/2021 and 58 on 4/27/2022; 197 RSUs which vest in two installments of 65 on 5/3/2021 and 5/3/2022 and one installment of 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; and 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment 495 on 11/2/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 56 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 02, 2021 Filed Mar 5, 2021 01:30 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 467 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-009481 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,113 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 63 RSUs which fully vest on 5/1/2021; 114 RSUs which vest in two installments of 56 on 4/27/2021 and 58 on 4/27/2022; 197 RSUs which vest in two installments of 65 on 5/3/2021 and 5/3/2022 and one installment of 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; and 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment 495 on 11/2/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 40 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 02, 2020 Filed Nov 5, 2020 00:02 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 1,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-028205 · form4.xml · nonDerivative · entry 1 Louie Linda H. · CIK 0001818953 · VP, Finance & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,632 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 63 RSUs which fully vest on 5/1/2021; 114 RSUs which vest in two installments of 56 on 4/27/2021 and 58 on 4/27/2022; 197 RSUs which vest in two installments of 65 on 5/3/2021 and 5/3/2022 and one installment of 67 on 5/3/2023; 169 RSUs which vest in installments of 55 on 5/5/2022, 56 on 5/5/2023 and 58 on 5/5/2024; and 1,453 RSUs which vest in two installments of 479 on 11/2/2022 and 11/2/2023 and one installment 495 on 11/2/2024. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 26 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.